Community network driven COVID-19 testing of vulnerable populations in the Central US
Community network driven COVID-19 testing of vulnerable populations in the Central US
批准号:
10274013
负责人:
HAROLD Alexander POLLACK
金额:
$123.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-15 至 2024-03-31
关键词:
AddressAdoptedAgeAwarenessCOVID-19COVID-19 impactCOVID-19 mortalityCOVID-19 preventionCOVID-19 susceptibilityCOVID-19 testingCommunitiesCommunity NetworksContact TracingCriminal JusticeDataDisease OutbreaksDrug CourtsEmploymentEnrollmentEnsureEthnic OriginFamilyFederally Qualified Health CenterFibrinogenFriendsGenderGenerationsHealthcareHouseholdHuman immunodeficiency virus testIndividualInfrastructureInterventionJailJusticeLatinxLeadLeadershipLinguisticsLow incomeMisinformationNational Institute of Drug AbuseOpioidPersonsPopulationPopulation HeterogeneityPrevention programPrisonsProceduresProcessPublic HealthRADx Underserved PopulationsRaceRandomizedReach Effectiveness Adoption Implementation and MaintenanceRecording of previous eventsResearchResourcesRiskRuralSARS-CoV-2 infectionSelf DeterminationSelf EfficacySiteSocial EnvironmentSocial NetworkSocial WorkTestingTrustUnited StatesVulnerable PopulationsWagescommunity centercommunity engagementcommunity partnershipcontextual factorscostdensitydisenfranchised populationdistrustefficacy testingevidence baseexperiencefederal poverty levelimplementation outcomesimplementation strategyinnovationmarginalized populationmemberparolepreferencepreventive interventionprobationprogramsrecruitruralitysecondary analysissocial contactsocial stigmasubstance usertesting servicestesting uptaketheoriestransmission process
中文摘要
这个C3项目,以社区网络为驱动,对中部脆弱人群进行新冠肺炎测试
将实施和评估新冠肺炎测试方法,将循证社会
网络测试策略(SNS)与社区开发的新冠肺炎公共卫生信息(SNS+)。C3将
在美国中部各州(德克萨斯州、洛杉矶州、
俄勒冈州,伊利诺伊州)C3利用NIDA的正义社区阿片类药物创新网络(JCOIN),PIS的广泛
位于社区的新冠肺炎测试计划,以及建立的社区合作伙伴网络。这个
协作社区-学术合作伙伴关系、研究和参与基础设施以及团队
JCOIN的领导力将确保C3能够迅速招募、招募和测试大多数被剥夺公民权的人
社区成员,(n=2,400),并通过这一进程,促进任何即将到来的新冠肺炎公共卫生
预防干预措施。C3聚焦受新冠肺炎影响最大的两个社区:1)刑事司法
涉案人员(CJI)-有逮捕/监狱/监狱、缓刑/假释和吸毒史的非监禁人员-
出庭人数;2)低收入拉美裔社区成员,低于联邦贫困水平的250%。
这两个不同的人群,以及他们之间的重叠,都有一些最高的新冠肺炎患病率
在美国的感染和死亡。确认个别机构并纠正错误信息的信息,
结合可访问和可接受的测试,以加快对这些问题的新冠肺炎预防
人口。我们使用上下文适应和理论驱动的信息-错误信息更正和自我
肯定-为了提高意识、自我效能和社区参与我们的适应测试策略-
社交网络测试策略(SNS)。SNS是一种以证据为基础的测试干预措施,已被广泛
在与被边缘化的个人(即吸毒者)的多个环境中使用,这些人促进招募
将他们的社交联系转化为测试服务。SNS与理论驱动的、适合国情的COVID相结合-
19条消息(sns+)将解决当前新冠肺炎测试战略面临的挑战,这些战略受到以下限制
错误信息、污名、不信任和对预防新冠肺炎能力的有限肯定。C3与
社区将:开发强调自我肯定和纠正错误信息的新冠肺炎消息
在社交网络中实施;测试组合的有效性(新冠肺炎测试的网络成员数量)
使用自适应随机化的SNS消息(SNS+)干预与标准SNS干预;并评估C3
使用RE-AIM框架的实施战略和关键实施成果(即成本)。这个
将从事C3工作的被剥夺公民权的人群反映了那些受新冠肺炎影响最大、最没有能力
采取新冠肺炎预防做法。C3已准备好在短时间内实施
RADX-UP机制,有重要的机构承诺和社区支持,以确保
为高危社区量身定做的、可行的、可接受的和有效的程序和干预措施。
英文摘要
This C3 project, Community network-driven COVID-19 testing of vulnerable populations in the Central
US, will implement and evaluate a COVID-19 testing approach that combines an evidence-based Social
Network Testing Strategy (SNS) with community developed COVID-19 public health messages (SNS+). C3 will
engage two disenfranchised populations across rural and urban sites in states across the Central US (TX, LA,
AR, IN, IL). C3 leverages NIDA's Justice Community Opioid Innovation Network (JCOIN), the PIs' extensive
community located COVID-19 testing programs, and a network of established community partnerships. The
collaborative community-academic partnerships, research and engagement infrastructure, and team's
leadership across JCOIN will ensure that C3 can rapidly recruit, enroll and test most disenfranchised
community members, (n=2400) and through this process, accelerate any forthcoming COVID-19 public health
prevention interventions. C3 focuses on two communities most impacted by COVID-19: 1) Criminal justice
involved (CJI) - non-incarcerated people with previous history of arrest/jail/prison, probation/parole and drug-
court attendance; and 2) Low-income Latinx - community members at 250% or below Federal Poverty Level.
Both of these diverse populations, and the overlap between them, have some of the highest rates of COVID-19
infection and death in the United States. Messaging that affirms individual agency and corrects misinformation,
combined with accessible and acceptable testing, is required to accelerate COVID-19 prevention for these
populations. We use contextually adapted and theory-driven messages – misinformation correction and self-
affirmation – to increase awareness, self-efficacy and community engagement in our adapted testing strategy –
the Social Network testing Strategy (SNS). SNS is an evidence-based testing intervention that has been widely
used in multiple settings with marginalized individuals (ie substance-users) who facilitate the recruitment of
their social contacts into testing services. SNS combined with theory-driven, contextually appropriate COVID-
19 messaging (SNS+) will address challenges to current COVID-19 testing strategies which are limited by
misinformation, stigma, distrust, and limited affirmation of ability to prevent COVID-19. C3 in partnership with
community will: Develop COVID-19 messages that emphasize self-affirmation and misinformation correction
for implementation in SNS; Test the efficacy (number of network members COVID-19 tested) of a combined
SNS-messaging (SNS+) intervention versus standard SNS using adaptive randomization; and Evaluate C3
implementation strategies and key implementation outcomes (ie cost) using the RE-AIM framework. The
disenfranchised populations to be engaged in C3 reflect those most impacted by COVID-19 and least able to
adopt COVID-19 prevention practices. C3 is “shovel-ready” for implementation in the short timeframe of the
RADx-UP mechanism, with significant institutional commitments and community support, to ensure the
procedures and interventions are tailored, feasible, acceptable and effective for at-risk communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alternate Emergency Over Dose Response in Chicago
-
批准号:10618266
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2022
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Alternate Emergency Over Dose Response in Chicago
-
批准号:10425012
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2022
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Reducing Opioid Mortality in Illinois (ROMI)
-
批准号:10402783
-
项目类别:
-
资助金额:$200.55万
-
财政年份:2019
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
-
批准号:10200643
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2019
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Reducing Opioid Mortality in Illinois (ROMI)
-
批准号:10671066
-
项目类别:
-
资助金额:$212.59万
-
财政年份:2019
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Predictive Analytics Applied to Integrated Administrative Emergency Response Datasets in Chicago - Resubmission 01
-
批准号:9981836
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2019
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Reducing Opioid Mortality in Illinois (ROMI)
-
批准号:9978033
-
项目类别:
-
资助金额:$229.79万
-
财政年份:2019
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Project 2: BAM
-
批准号:8741896
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2014
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Project 2: BAM
-
批准号:9099542
-
项目类别:
-
资助金额:$14.38万
-
财政年份:--
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
Project 2: BAM
-
批准号:8895087
-
项目类别:
-
资助金额:$14.52万
-
财政年份:--
-
负责人:HAROLD Alexander POLLACK
-
依托单位:
海外基金